Get the app
US › Healthcare

Voyager Therapeutics Inc (VYGR)

US · Healthcare · Biotechnology

$3.04-0.33%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$3.2M
Revenue YoY
-39.1%
Net profit
$-24.5M
EPS
$-0.40
EPS estimate
$-0.55
Net margin
-773.2%

EPS came in at -0.40 against a street estimate of -0.55 — a beat of 27.3%.

Key statistics

Market cap
$196.6M
Forward P/E
8.4
P/B
1.28
Book value
$2.88
EPS (TTM)
$-1.81
52-week high
$5.55
52-week low
$2.94
50-day MA
$3.30
200-day MA
$3.76
Beta
1.32

Analyst view

Analysts rate Voyager Therapeutics Inc a strong buy (12 buy, 0 hold, 0 sell out of 12) with an average price target of $14.89.

Shareholding

Insiders
14.84%
Institutions
57.87%

Largest institutional holders

FundStake
BlackRock Inc9.04%
Millennium Management LLC7.21%
Armistice Capital, LLC5.68%
Vestal Point Capital LP4.87%
Vanguard Capital Management, LLC3.71%
Opaleye Management Inc1.92%
Erste Asset Management GmbH1.78%
Geode Capital Management, LLC1.70%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Voyager Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.